Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous milrinone for treatment and prophylaxis of subarachnoid hemorrhage-induced vasospasm
2009-016620-32Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of milrinone in cerebral vasospasm, sponsored by Medical University of Vienna. Primary endpoint: Glasgow Outcome Scale Extended (GOSE). Started Jul 2012; status: completed.
02
Drugs
milrinone
03
Conditions
cerebral vasospasm
Beyond the preview
Go deeper on 2009-016620-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016620-32.